Department of Pharmacy, Health Science and Nutrition, University of Calabria, Arcavacata di Rende, Cosenza, Italy.
Pathologic Anatomy Unit, Annunziata Hospital, Cosenza, Italy.
Andrology. 2018 Jan;6(1):192-198. doi: 10.1111/andr.12443. Epub 2017 Nov 16.
Oestrogen targeting in the human genital ducts is still not well-known. In fact, to date, the localization of oestrogen receptors, ESR1 and ESR2, is controversial and the presence of the membrane oestrogen receptor GPER (G protein-coupled oestrogen receptor) is unexplored. This study has investigated the expression of GPER, ESR1, ESR2 in human ductuli efferentes and proximal caput epididymis by immunohistochemistry and Western blot analysis. Furthermore, the presence of PELP1 (proline-glutamic acid-leucine-rich protein 1), a co-regulator of the oestrogen receptors, was also evaluated. In ductuli efferentes, GPER and ESR1 were clearly localized in all epithelial cells, while ESR2 was evidenced only in ciliated cells. Conversely, the epithelial cells of proximal caput epididymis revealed moderate GPER immunoreactivity, the absence of ERS1 and the occasional presence of ESR2. Furthermore, PELP1 was observed in ciliated cells of ductuli efferentes and in principal cells of proximal caput epididymis. Therefore, this study firstly demonstrated the expression of GPER in human male genital ducts, revealing a new mediator of oestrogen action in these anatomical sites. ESR1 and ESR2 were differentially localized in the two genital tracts together with PELP1, but cell sites of ERs and their co-regulator were not homogeneous. So, a different regional/cellular association of GPER with the classical oestrogen receptors was highlighted, suggesting that oestrogen action could be mediated by GPER, ESR1, ESR2 in ductuli efferentes, while by GPER and, occasionally by ESR2, in proximal caput epididymis. This study suggests that the specific oestrogen-mediated functions in human genital ducts might result from the different local interactions of oestrogens with oestrogen receptors and their co-regulators.
雌激素在人体生殖道中的靶向作用仍不为人知。事实上,迄今为止,雌激素受体 ESR1 和 ESR2 的定位仍存在争议,而膜雌激素受体 GPER(G 蛋白偶联雌激素受体)的存在尚未被探索。本研究通过免疫组织化学和 Western blot 分析研究了 GPER、ESR1 和 ESR2 在人类输出小管和附睾近端头部的表达。此外,还评估了雌激素受体的共同调节剂 PELP1(脯氨酸-谷氨酸-亮氨酸丰富蛋白 1)的存在。在输出小管中,GPER 和 ESR1 均明显定位于所有上皮细胞,而 ESR2 仅见于纤毛细胞。相反,附睾近端头部的上皮细胞显示中等强度的 GPER 免疫反应性,缺乏 ERS1,偶尔存在 ESR2。此外,在输出小管的纤毛细胞和附睾近端头部的主细胞中观察到 PELP1。因此,本研究首次在人体男性生殖道中证实了 GPER 的表达,揭示了雌激素在这些解剖部位作用的新介质。ESR1 和 ESR2 与 PELP1 一起在两个生殖道中呈现不同的定位,但 ERs 和它们的共同调节剂的细胞部位并不均匀。因此,GPER 与经典雌激素受体的不同区域/细胞相关性被强调,表明雌激素作用可能通过 GPER、ESR1 和 ESR2 在输出小管中介导,而在附睾近端头部则通过 GPER 和偶尔通过 ESR2 介导。本研究表明,人类生殖道中特定的雌激素介导功能可能源于雌激素与雌激素受体及其共同调节剂的不同局部相互作用。